연구동향 분석

Studies on optimizing therapeutic strategies for the treatment of Tauopathy using mesenchymal stem cells = 타우 병증 중간엽 줄기세포 치료제의 치료 전략에 대한 다각적 연구

김형섭 2020년

논문상세정보
인용/피인용
' Studies on optimizing therapeutic strategies for the treatment of Tauopathy using mesenchymal stem cells = 타우 병증 중간엽 줄기세포 치료제의 치료 전략에 대한 다각적 연구' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • agouti-related neuropeptide
  • ghrelin
  • induced pluripotent stem cell
  • injection route
  • mesenchymal stem cell
  • optimal concentration
  • tauopathy
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
103 0

0.0%

' Studies on optimizing therapeutic strategies for the treatment of Tauopathy using mesenchymal stem cells = 타우 병증 중간엽 줄기세포 치료제의 치료 전략에 대한 다각적 연구' 의 참고문헌

  • Y. Ghrelin : much more than a hunger hormone .
    16 , 619 -- 624 , doi:10.1097/MCO.0b013e328365b9be [2013]
  • The endotoxin hypothesis of neurodegeneration
    16 , 180 , doi:10.1186/s12974 019 1564 7 . [2019]
  • Tau driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP PKA signaling
    22 , 46 53 , doi:10.1038/nm.4011 [2016]
  • S. iPSCells : a gameChanger for future medicine
    33 , 409 -- 417 , doi:10.1002/embj.201387098 [2014]
  • S. Induced pluripotent stemCell technology : a decade of progress
    16 , 115 -- 130 , doi:10.1038/nrd.2016.245 [2017]
  • R. Mesenchymal StemCell Secretome : TowardCell Free Therapeutic Strategies in Regenerative Medicine
    18 , doi:10.3390/ijms18091852 [2017]
  • Q. Paracrine mechanisms of mesenchymal stemCell -based therapy :Current status and perspectives .
    23 , 1045 -- 1059 , doi:10.3727/096368913X667709 [2014]
  • P. The ubiquitin proteasome system as a potential therapeutic target for treatment of neurodegenerative diseases
    34 , 337 352 , doi:10.4149/gpb_2015024 [2015]
  • P. Overview of cell and tissue culture techniques
    Chapter 12 , Unit12 11 , doi:10.1002/0471141755.ph1201s04 . [2001]
  • Network of hypothalamic neurons that control appetite
    48 , 229 -- 233 , doi:10.5483/bmbrep.2015.48.4.272 [2015]
  • Mesenchymal stem cells : a new trend for cell therapy
    34 , 747 -- 754 , doi:10.1038/aps.2013.50 . [2013]
  • Mechanisms of mesenchymal stem/stromal cell function .doi:10.1186/s13287 -- 016 -- 0363 -- 7
    7 , 125 [2016]
  • M. Tau and tauopathies .
    126 , 238 292 , doi:10.1016/j.brainresbull.2016.08.018 . [2016]
  • M. From in vitro Experiments to in vivo and Clinical Studies ; Pros and Cons .
    12 , 218 -- 224 , doi:10.2174/1570163813666160114093140 . [2015]
  • K. Abnormal hyperphosphorylation of tau : sites , regulation , and molecular mechanism of neurofibrillary degeneration
    33 Suppl 1 , S123 139 , doi:10.3233/JAD 2012 129031 . [2013]
  • J. Tauopathies .
    64 , 2219 2233 , doi:10.1007/s00018 007 7220 x [2007]
  • Induced pluripotent stem cells in disease modelling and drug discoverydoi:10.1038/s41576 -- 019 -- 0100 -- z
    20 , 377 -- 388 [2019]
  • Immortality of cell lines : challenges and advantages of establishment
    37 , 1038 -- 1045 , doi:10.1002/cbin.10137 . [2013]
  • H. Integration -- free T cell -- derived human induced pluripotent stem cells ( iPSCs ) from a patient with lymphedema -- distichiasis syndrome ( LDS ) carrying an insertion -- deletion complex mutation in the FOXC2 gene
    16 , 611 -- 613 , doi:10.1016/j.scr.2016.03.004 . [2016]
  • H. Disease Modeling in Stem Cell -- Derived 3D Organoid Systems
    23 , 393 -- 410 , doi:10.1016/j.molmed.2017.02.007 . [2017]
  • Ghrelin regulation of glucose metabolism
    100 , 236 -- 242 , doi:10.1016/j.peptides.2017.12.015 [2018]
  • F. Neuroendocrine control of food intake .
    18 , 158 -- 168 , doi:10.1016/j.numecd.2007.06.004 [2008]
  • E. Tau in physiology and pathology
    17 , 5 21 , doi:10.1038/nrn.2015.1 [2016]
  • Diabetes and Insulin .doi:10.1007/978 -981 -32 -9358 -8_21 .
    1184 , 259 -- 287 [2019]
  • D.C. Tau degradation : the ubiquitin proteasome system versus the autophagy lysosome system
    105 , 49 59 , doi:10.1016/j.pneurobio.2013.03.001 . [2013]
  • D. The ubiquitin proteasome system
    31 , 137 155 , doi:10.1007/BF02705243 . [2006]
  • D. Tau and neuroinflammation : What impact for Alzheimer 's Disease and Tauopathies ?
    41 , 21 33 , doi:10.1016/j.bj.2018.01.003 . [2018]
  • Current Challenges of iPSC -- Based Disease Modeling and Therapeutic Implications
    8 , doi:10.3390/cells8050403 [2019]
  • Autophagy and Ubiquitin Proteasome System
    1206 , 527 550 , doi:10.1007/978 981 15 0602 4_25 . [2019]
  • Amyloid -- beta and tau : the trigger and bullet in Alzheimer disease pathogenesis
    71 , 505 -- 508 , doi:10.1001/jamaneurol.2013.5847 [2014]
  • A Brief Overview of Tauopathy : Causes , Consequences , and Therapeutic Strategies
    38 , 637 648 , doi:10.1016/j.tips.2017.03.011 . [2017]
  • 9. Dikic, I. Proteasomal and Autophagic Degradation Systems. Annu Rev Biochem 2017, 86, 193 224, doi:10.1146/annurev biochem 061516 044908.
  • 4. Bennett, R.E.; DeVos, S.L.; Dujardin, S.; Corjuc, B.; Gor, R.; Gonzalez, J.; Roe, A.D.; Frosch, M.P.; Pitstick, R.; Carlson, G.A., et al. Enhanced Tau Aggregation in the Presence of Amyloid beta. Am J Pathol 2017, 187, 1601 1612, doi:10.1016/j.ajpath.2017.03.011.
  • 30. An update on organoid research. Nat Cell Biol 2018, 20, 633, doi:10.1038/s41556--018--0119--y.
  • 24. Li, L.; Roh, J.H.; Chang, E.H.; Lee, Y.; Lee, S.; Kim, M.; Koh, W.; Chang, J.W.; Kim, H.J.; Nakanishi, M., et al. iPSC Modeling of Presenilin1 Mutation in Alzheimer's Disease with Cerebellar Ataxia. Exp Neurobiol 2018, 27, 350--364, doi:10.5607/en.2018.27.5.350.
  • 20. Lee, N.K.; Park, S.E.; Kwon, S.J.; Shim, S.; Byeon, Y.; Kim, J.H.; Na, D.L.; Chang, J.W. Agouti Related Peptide Secreted Via Human Mesenchymal Stem Cells Upregulates Proteasome Activity in an Alzheimer's Disease Model. Sci Rep 2017, 7, 39340, doi:10.1038/srep39340.
  • 13. Oddo, S. The ubiquitin proteasome system in Alzheimer's disease. J Cell Mol Med 2008, 12, 363 373, doi:10.1111/j.1582 4934.2008.00276.x.